We’ve joined The Economist Events’ War on Cancer Forum as a partner!
SERMO Members Get Discounted Admission with Promo Code SERMO350
We’re excited to announce that we’ve joined The Economist Events’ War on Cancer Forum as a partner and SERMO members will get discounted admission. The forum will include senior leaders from Dana-Farber, MD Anderson, City of Hope and National Institutes of Health.
We all know the practice of oncology is getting more expensive and challenging. The goal of this conference is to facilitate collaboration among members of the health care ecosystem to truly unleash innovation, efficiency and patient-centricity. It will bring together pharmaceutical companies, hospitals, regulators, patient care advocates and insurers to discuss how to scale innovation and drive down costs through breakthroughs in science, cutting-edge technologies, regulation and most of all, a growing appetite for cooperation.
A little more about conference:
The Economist Events’ Health Care Forum: The War on Cancer on September 29, will gather influencers, policymakers, oncology experts, researchers and pharmaceutical and insurance executives to explore innovations in the war on cancer and ways to rein in costs, including simpler models of care, less expensive drugs and the move away from fee-for-service to outcomes-based remuneration. Industry leaders will also discuss which cancers are actually preventable, the importance of big data and the role that technology plays in altering people’s behaviors for improved health.
The War on Cancer conference is part of a global event series, the first of which took place in Hong Kong in March, with the final conference to be held in London this October. The Boston event will be chaired by The Economist’s healthcare correspondent Natasha Loder (@natashaloder).
“There are exciting new developments emerging in the war on cancer, but there is still much to learn if we want to defeat it,” said Loder.
– Edward Benz, Chief executive and president, Dana-Farber Cancer Institute
– Krishna Yeshwant, General partner, Google Ventures
– Edward Trimble, Director, center for global health, National Institutes of Health
- Steve Miller, Senior vice-president and chief medical officer, Express Scripts
- Jennifer Malin, Vice-president, clinical strategy, Anthem, Inc.
- Bahija Jallal, Executive vice-president, AstraZeneca and director, MedImmune
- Martha Donoghue, Clinical reviewer, hematology and oncology products, US Food and Drug Administration
- John Lin, Chief scientific officer, Oncology-Rinat, Pfizer Worldwide Research and Development
- Otis Brawley, Chief medical and scientific officer, executive vice-president of research, American Cancer Society
If you’re a physician, please join us inside SERMO.